MORTALITY OF IRON FOUNDRY WORKERS .4. ANALYSIS OF A SUBCOHORT EXPOSEDTO FORMALDEHYDE

Citation
Da. Andjelkovich et al., MORTALITY OF IRON FOUNDRY WORKERS .4. ANALYSIS OF A SUBCOHORT EXPOSEDTO FORMALDEHYDE, Journal of occupational and environmental medicine, 37(7), 1995, pp. 826-837
Citations number
55
Categorie Soggetti
Public, Environmental & Occupation Heath
ISSN journal
10762752
Volume
37
Issue
7
Year of publication
1995
Pages
826 - 837
Database
ISI
SICI code
1076-2752(1995)37:7<826:MOIFW.>2.0.ZU;2-O
Abstract
In the final phase of the mortality study of workers at an automotive iron foundry, a subset (N = 3929) of the original cohort of 8147 men, consisting of those exposed to formaldehyde during the period from Jan uary 1960 through May 1987, was analyzed. In addition to the external US population, an internal population (N = 2032), consisting of men wh o had worked in the same foundry during the same time period but not i n formaldehyde-exposed jobs, was also used as a referent. Follow-up co ntinued through December 31, 1989. Smoking status was ascertained for 65.4% of the exposed and for 55.1% of the unexposed cohorts. Detailed work histories and evaluation of occupational exposures by an industri al hygienist enabled us to categorize cumulative formaldehyde and sili ca exposures. Standardized mortality ratios were used to compare the m ortality experience of the exposed cohort with the US population and, because of concerns about the healthy worker effect, with an occupatio nal referent population. Relative risks for race, formaldehyde exposur e status, smoking status, and silica exposure level were estimated by fitting a Poisson regression model to four causes of death: cancers of the buccal cavity and pharynx, lung cancer, diseases of the respirato ry system, and emphysema. No association between formaldehyde exposure and deaths from malignant or nonmalignant diseases of the respiratory system was found. Cigarette smoking and silica exposure were found to be significantly associated with deaths attributed to lung cancer and disease of the respiratory system.